Delivery of Immunoprophylactics in Transgenic Plants: Current Status.
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 381, doi. 10.2165/00063030-200013060-00001
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2000 AND VI 13 AND IP 6
Results: 7
1
2
Leptin in the Pathophysiology of Human Obesity and the Clinical Potential of Leptin-Based Therapy.
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 391, doi. 10.2165/00063030-200013060-00002
- By:
- Publication type:
- Article
3
The Potential of Newer Immunomodulating Drugs in the Treatment of Uveitis: A Review.
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 397, doi. 10.2165/00063030-200013060-00003
- By:
- Publication type:
- Article
4
Intestinal Behçet’s Disease: Epidemiology, Pathophysiology and Potential of Mesalazine.
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 409, doi. 10.2165/00063030-200013060-00004
- By:
- Publication type:
- Article
5
Optimisation of the Treatment of Acute Gout.
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 415, doi. 10.2165/00063030-200013060-00005
- By:
- Publication type:
- Article
6
In-Capromab Pendetide: The Evolution of Prostate Specific Membrane Antigen and the Nuclear Imaging of its In-Labelled Murine Antibody in the Evaluation of Prostate Cancer.
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 437
- By:
- Publication type:
- Article
7
Management of the Patient with Severe Refractory Rheumatoid Arthritis: Are the Newer Treatment Options Worth Considering?
- Published in:
- BioDrugs, 2000, v. 13, n. 6, p. 425, doi. 10.2165/00063030-200013060-00006
- By:
- Publication type:
- Article